Atlas Trials

Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women

Clinical trial NCT01041092 · COMPLETED

Trial details

NCT number
NCT01041092
Sponsor
Fundació Sant Joan de Déu
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2004-06-01
Primary completion
2009-12-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.